About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg Impact Factor
h-index
g-index
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Massachusetts General Hospital
›
Top Articles
Massachusetts General Hospital
United States of America
()
322.4K
(top 1%)
articles
10.3M
(top 1%)
citations
61,871
(top 1%)
★★
articles
6,075
(top 1%)
★★★
articles
2.7
(top 17%)
Avg IF
840
(top 1%)
H-Index
1,337
(top 1%)
G-Index
10,764
journals
Most Cited Articles of Massachusetts General Hospital in 2022
Title
Journal
Year
Citations
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.
Cell
2022
204
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.
Science
2022
124
Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
Nature
2022
35
Reproducible brain-wide association studies require thousands of individuals.
Nature
2022
34
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.
Cell
2022
20
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation.
Nature
2022
20
A roadmap to increase diversity in genomic studies.
Nature Medicine
2022
18
Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses.
Cell
2022
17
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals.
Cell
2022
17
Migraine.
Nature Reviews Disease Primers
2022
16
Rare coding variants in ten genes confer substantial risk for schizophrenia.
Nature
2022
16
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain
Science
2022
15
Placental Tissue Destruction and Insufficiency from COVID-19 Causes Stillbirth and Neonatal Death from Hypoxic-Ischemic Injury: A Study of 68 Cases with SARS-CoV-2 Placentitis from 12 Countries.
Archives of Pathology and Laboratory Medicine
2022
14
Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue.
JAMA Oncology
2022
13
Access to gender-affirming hormones during adolescence and mental health outcomes among transgender adults.
PLoS ONE
2022
12
Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants.
Nature Medicine
2022
12
Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: Readmissions After Left Ventricular Assist Device.
Annals of Thoracic Surgery
2022
11
Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders
Biological Psychiatry
2022
11
Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection.
JAMA - Journal of the American Medical Association
2022
10
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with Fusion-Positive Solid Tumors.
Clinical Cancer Research
2022
10
Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease.
JAMA Network Open
2022
10
Large-scale neural recordings with single neuron resolution using Neuropixels probes in human cortex.
Nature Neuroscience
2022
9
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
JAMA Neurology
2022
9
SARS-CoV-2 placentitis associated with B.1.617.2 (Delta) variant and fetal distress or demise.
Journal of Infectious Diseases
2022
9
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.
The Lancet Gastroenterology and Hepatology
2022
9
site/software ©
exaly
; All materials licenced under
CC by-SA
.